Twin Tree Management, LP Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Twin Tree Management, LP

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	SELL	$1024.09 - $1201.76 $13.5 Million - $15.9 Million	-13,200 Reduced 75.43%	4,300 $4.52 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $441,600 - $535,595	500 Added 2.94%	17,500 $18.4 Million
Q1 2024 May 09, 2024	BUY	$902.69 - $993.35 $15.3 Million - $16.9 Million	17,000 New	17,000 $16.4 Million
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $907,686 - $1.33 Million	2,700 New	2,700 $1.32 Million
Q2 2019 Aug 12, 2019	SELL	$299.6 - $414.82 $2.88 Million - $3.98 Million	-9,600 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$372.08 - $439.57 $3.13 Million - $3.69 Million	8,400 Added 700.0%	9,600 $3.94 Million
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $6.85 Million - $8.22 Million	-20,400 Reduced 94.44%	1,200 $448,000
Q3 2018 Nov 09, 2018	SELL	$351.14 - $408.51 $70,228 - $81,702	-200 Reduced 0.92%	21,600 $8.73 Million
Q2 2018 Aug 08, 2018	BUY	$284.6 - $344.99 $3.02 Million - $3.66 Million	10,600 Added 94.64%	21,800 $7.52 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $4.83 Million - $5.64 Million	11,200	11,200 $5.01 Million

1,497

82.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.